AtomVie Global Radiopharma raises over $90M to Complete its New Facility Buildout
Comunicato Precedente
Comunicato Successivo
"Avego is pleased to expand its partnership with AtomVie, a collaboration that underscores our commitment to growth and innovation. AtomVie's new facility, set to open in late 2024, will handle meaningful clinical and commercial programs with advance booking of manufacturing capacity available today" said Kevin McNeill, Partner at Avego.
AtomVie will be exhibiting at the 2023 SNMMI Annual Meeting, during which further highlights of its new facility will be unveiled at Booth #2024.
AtomVie, a spinout of the Centre for Probe Development and Commercialization (CPDC), is a global leading CDMO for the GMP manufacturing and global distribution of clinical and commercial radiopharmaceuticals. Building upon the expertise and high-quality services since 2008 from CPDC, AtomVie offers the full range of scientific, technical, regulatory, quality, logistics and business expertise combined with a specialized infrastructure for the development of radiopharmaceuticals from clinical studies to the commercial marketplace. AtomVie currently serves international clients conducting studies in over 17 countries worldwide.
Avego, founded in 2015 by former healthcare entrepreneurs, is a multi-strategy healthcare-focused investment firm with offices in Georgia and New York. Through its three strategies, which include private equity, venture capital, and a hedge fund, Avego invests in private and public companies developing and commercializing innovative products and services for patients, practitioners, and other stakeholders across the healthcare continuum. To learn more about Avego, visit www.avego.com or contact: contact@avego.com.
about AtomVie, visit www.atomvie.com or contact: info@atomvie.com
Logo - https://mma.prnewswire.com/media/2088805/AtomVie_Global_Radiopharma_Inc__AtomVie_Global_Radiopharma_raise.jpg
Logo - https://mma.prnewswire.com/media/2088806/AtomVie_Global_Radiopharma_Inc__AtomVie_Global_Radiopharma_raise.jpg
View original content:https://www.prnewswire.co.uk/news-releases/atomvie-global-radiopharma-raises-over-90m-to-complete-its-new-facility-buildout-301838736.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
